Sleep Apnea Diagnostics Market Size & Growth Report by 2028
The sleep apnea diagnostics market is projected to reach US$ 685.66 million by 2028 from US$ 473.95 million in 2021; it is estimated to grow at a CAGR of 5.4% from 2021 to 2028
Sleep apnea is a common type of sleep disorder that happens when an individual is having trouble in breathing during sleep where breathing repeatedly stops and starts. Sleep apnea devices are primarily provided as diagnostic and therapeutic devices in order to treat obstructive sleep apnea syndrome, central sleep apnea syndrome and complex sleep apnea syndrome. Continuous positive airway pressure is widely recommended device to treat obstructive sleep apnea.
Factors such as increased sleep apnea prevalence, technological developments, and rising geriatric population are boosting the sleep apnea diagnostics market growth. However, the high cost of diagnosis, and challenges in medical device industry hamper the growth of the market.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Sleep Apnea Diagnostics Market: Strategic Insights
Sleep Apnea Diagnostics Market
-
CAGR (2021 - 2028)
5.4%
-
Market Size 2021
US$ 473.95 Million
-
Market Size 2028
US$ 685.66 Million
Market Dynamics
GROWTH DRIVERS
- XXXXXXX
- XXXXXXX
- XXXXXXX
FUTURE TRENDS
- XXXXXXX
- XXXXXXX
- XXXXXXX
OPPORTUNITIES
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Drive DeVilbiss International
- ResMed Inc
- Nihon Kohden Corporation
- SOMNOmedics GmbH
- Cleveland Medical Devices Inc
- Koninklijke Philips N V
- Cadwell Industries Inc
- Natus Medical Incorporated
- Itamar Medical Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product
- Polysomnography Device
- Home Sleep Testing Devices
- Oximeter
- Actigraphy Monitoring Device
- Sleep Apnea Screening Device
End User
- Hospitals and Sleep Laboratories
- Home Care Settings
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Sleep Apnea Diagnostics Market: Strategic Insights
-
CAGR (2021 - 2028)5.4% -
Market Size 2021
US$ 473.95 Million -
Market Size 2028
US$ 685.66 Million
Market Dynamics
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
- XXXXXXX
Key Players
- Drive DeVilbiss International
- ResMed Inc
- Nihon Kohden Corporation
- SOMNOmedics GmbH
- Cleveland Medical Devices Inc
- Koninklijke Philips N V
- Cadwell Industries Inc
- Natus Medical Incorporated
- Itamar Medical Ltd
Regional Overview
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Market Segmentation
Product - Polysomnography Device
- Home Sleep Testing Devices
- Oximeter
- Actigraphy Monitoring Device
- Sleep Apnea Screening Device
End User - Hospitals and Sleep Laboratories
- Home Care Settings
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Insights
Increased Prevalence of Sleep Apnea Boosts Sleep Apnea Diagnostics Market Growth
Obstructive sleep apnea (OSA) is a common disorder, characterized by the repetitive, complete or partial closure of the upper airway during sleep. This airway is helpful in the fragmentation of sleep and oxygen desaturation. The disorder causes significant morbidity, especially in the form of impairment of daytime functioning and degraded quality of life. As per recent controlled trials, oral appliances are up to 50.0% efficient in controlling the OSA among patients, including severe cases.
According to a survey conducted by Needham & Company, an investment firm, over one-third of OSA tests were conducted in patients' homes in 2018, up from 15% in 2013. As a result, companies are concentrating their efforts on the development of home-care sleep apnea equipment. In June 2019, the FDA approved Itamar Medical, an Israel-based business, for a disposable home sleep apnea test. ResApp (Australia), a firm that develops smartphone applications for the diagnosis and management of respiratory disorders, has launched SleepCheck, an at-home screening app for the OSA.
Due to the rising use of the polysomnography (PSG) device in the various regions, the need for improved and technologically advanced PSG devices for the diagnosis of OSA has surged substantially, thus driving the global sleep apnea diagnostics market.
Product and Service-Based Insights
Based on product, the sleep apnea diagnostics market is segmented into polysomnography (PSG) device, home sleep testing devices, oximeter, actigraphy monitoring device, and sleep apnea screening device. The oximeter segment is further segmented into fingertip oximeter, handheld oximeter, wrist-worn oximeter, and tabletop oximeter. The PSG device segment is expected to hold the largest share of the market in 2021, and it is further expected to register the highest CAGR during the forecast period.
End-User -Based Insights
Based on end-user, the sleep apnea diagnostics market is segmented into hospitals and sleep laboratories, and home care settings. The hospitals and sleep laboratories segment is expected to hold a larger market share in 2021, whereas the home care settings segment is expected to register a higher CAGR in the market during the forecast period
Various companies operating in the sleep apnea diagnostics market are adopting strategies such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain brand name, and meet the growing demand from end users.
Sleep Apnea Diagnostics Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 473.95 Million |
| Market Size by 2028 | US$ 685.66 Million |
| Global CAGR (2021 - 2028) | 5.4% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Sleep Apnea Market – by Product
- Polysomnography (PSG) Device
- Home Sleep Testing Devices
- Oximeter
- Fingertip Oximeter
- Hand held oximeter
- Wrist-Worn Oximeter
- Tabletop Oximeter
- Actigraphy Monitoring Device
- Sleep Apnea Screening Device
Sleep Apnea Diagnostics Market – by End User
- Hospital and sleep laboratories
- Home Care Settings
Sleep Apnea Diagnostics Market – by Geography
- North America
- US
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- UK
- Spain
- Rest of Europe
- Asia Pacific (APAC)
- China
- India
- South Korea
- Japan
- Australia
- Rest of Asia Pacific
- Middle East & Africa (MEA)
- South Africa
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
- South America (SAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- Drive DeVilbiss International
- ResMed Inc.
- Nihon Kohden Corporation
- SOMNOmedics GmbH
- Cleveland Medical Devices Inc
- Koninklijke Philips N.V.
- Cadwell Industries Inc
- Natus Medical Incorporated
- Itamar Medical Ltd.
- Compumedics Limited
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, End User, and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global sleep apnea diagnostics market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The US is estimated to hold the largest share in the sleep apnea diagnostics market during the forecast period. The high prevalence of sleep apnea and rising awareness about sleep apnea and its risk factors. However, increasing number of R&D activities, innovative technology and products, and increasing number of medical devices increasing chronic diseases, in the Asia-Pacific is expected to account for the fastest growth of the region during the coming years.
The sleep apnea diagnostics market majorly consists of the players such as Drive DeVilbiss International, ResMed Inc, Nihon Kohden Corporation, SOMNOmedics GmbH, Cleveland Medical Devices Inc, Koninklijke Philips N.V., Cadwell Industries Inc, Natus Medical Incorporated, Itamar Medical Ltd., Compumedics Limited, among others
The Polysomnography (PSG) Device segment dominated the global sleep apnea diagnostics market and held the largest revenue share of 59.09% in 2021.
The hospitals and sleep laboratories segment dominated the global sleep apnea diagnostics market and accounted for the largest revenue share of 73.61% in 2021.
Sleep apnea is a common type of sleep disorder that happens when an individual is having trouble in breathing during sleep where breathing repeatedly stops and starts. Sleep apnea devices are primarily provided as diagnostic and therapeutic devices in order to treat obstructive sleep apnea syndrome, central sleep apnea syndrome and complex sleep apnea syndrome. Continuous positive airway pressure is widely recommended device to treat obstructive sleep apnea.
Key factors that are driving the growth of this market are increased prevalence of sleep apnea, technological developments, rising geriatric population, and growing medical device industry.
Get Free Sample For